Drug intelligence / Profile preview

Vitagel

Development stage
Phase 4
Lead developer
Stryker
Modality
Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Vitagel is an FDA-approved surgical hemostat and combination product designed to facilitate hemostasis and tissue healing across various surgical specialties, including orthopedic, cardiac, and general surgery. The product is a composite of bovine microfibrillar collagen and bovine thrombin, which are mixed at the point of care with a small volume of the patient's own plasma (autologous plasma). Upon application to a bleeding site, usually via a spray device, the thrombin reacts with the fibrinogen in the plasma to form a fibrin-collagen gel matrix. This matrix incorporates the patient's activated platelets and adheres to the tissue, providing a physical scaffold for clot formation and subsequent wound healing. Vitagel is typically resorbed by the body within 30 days. It was originally developed as CoStasis before being rebranded and marketed as Vitagel.

Brand names
VitagelCoStasis
Other names
Vitagel Surgical HemostatCoStasis Surgical Hemostat
02

Targets

F5 (Coagulation Factor V)F8 (Coagulation Factor VIIIa)F11 (Coagulation Factor XI)Coagulation Factor XIIIF2R (Protease-activated receptor 1)PAR2 (Protease-activated receptor 2)PAR4 (Protease-activated receptor 4)

Beyond the preview

Go deeper on Vitagel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitagel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call